Related Experiment Videos
A Digital Diabetes Self-Management Education and Support Program Integrated With Continuous Glucose Monitoring for
Ashley Berthoumieux1, Jeanean B Naqvi1, Sean Zion1
1Omada Health, 500 Sansome St, #200, San Francisco, CA, 94111, United States, 1 4128746505.
Journal of Medical Internet Research
|May 14, 2026
Summary
A digital diabetes self-management education and support (DSMES) program combined with continuous glucose monitoring (CGM) improved glycemic control in adults with type 2 diabetes. This integrated approach demonstrated significant benefits in managing the condition over six months.
Area of Science:
- Endocrinology
- Digital Health
- Diabetes Management
Background:
- Continuous glucose monitoring (CGM) and digital diabetes self-management education and support (DSMES) programs can improve glycemic control in type 2 diabetes.
- Limited evidence exists on the combined benefits of digitally delivered DSMES and real-time CGM for adults with type 2 diabetes.
Purpose of the Study:
- To evaluate the impact of a DSMES program integrated with CGM on hemoglobin A1c (HbA1c) and CGM-derived glycemic measures.
- To compare the effectiveness of digital DSMES+CGM against usual care in adults with type 2 diabetes over a 6-month period.
Main Methods:
- Randomized controlled trial involving adults with type 2 diabetes and HbA1c ≥8%.
- Intervention group received a digital DSMES+CGM integrated solution; control group received usual care for 6 months.
- Primary outcome: HbA1c. Secondary outcomes: CGM-derived glycemic measures (glucose management indicator, time in range, time above range, mean glucose).
Main Results:
- The intervention group showed a statistically significant reduction in HbA1c at 3 months (P=.03).
- At 6 months, the digital DSMES+CGM group demonstrated significant improvements in glucose management indicator (P=.03), time in range (P=.04), time above range (P=.04), and mean glucose (P=.03) compared to usual care.
Conclusions:
- The combination of digital DSMES and CGM is effective in supporting adults with type 2 diabetes management.
- This integrated digital health solution holds potential for reducing long-term diabetes-related health complications.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...